The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling.
- DOI
- 10.1186/s13058-023-01715-3
- Published
- 2023 Nov 15
- Container
- Breast cancer research : BCR
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13058-023-01715-3,
title = {The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling.},
author = {Sharma D and Hager CG and Shang L and Tran L and Zhu Y and Ma A and Magnuson B and Lesko MW and Wicha MS and Burness ML},
year = {2023},
journal = {Breast cancer research : BCR},
doi = {10.1186/s13058-023-01715-3},
url = {https://doi.org/10.1186/s13058-023-01715-3}
}RIS
TY - JOUR TI - The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling. AU - Sharma D AU - Hager CG AU - Shang L AU - Tran L AU - Zhu Y AU - Ma A AU - Magnuson B AU - Lesko MW AU - Wicha MS AU - Burness ML PY - 2023 JO - Breast cancer research : BCR DO - 10.1186/s13058-023-01715-3 UR - https://doi.org/10.1186/s13058-023-01715-3 ER -
APA
D, S., CG, H., L, S., L, T., Y, Z., A, M., B, M., MW, L., MS, W., & ML, B. (2023). The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling.. Breast cancer research : BCR. https://doi.org/10.1186/s13058-023-01715-3
Source records
- pubmed · retrieved 2026-09-27T01:35:23.858Z